AIM2 and cancer: Follow-up research should therefore also include a deeper understanding of macrophage AIM2-triggered cancer cell death, specifically looking at pyroptosis-, apoptosis- and autophagic-driven mechanisms, to determine the effectiveness of rFIP-nha as an anti-cancer immunotherapeutic.